Wound-healing, anti-inflammatory, and antioxidant activities of β-glucan from red sea-mangroves-associated Candida tropicalis

Résumé

Marine yeasts are underexplored resource for bioactive polysaccharides with potential pharmaceutical activities. In this study, five marine yeast isolates from mangrove shrubs were screened for β-glucan production. Isolate Y4 exhibited the highest β-glucan yield, reaching 17.11% of cell fresh weight- approximately 1.57-fold higher than Saccharomyces cerevisiae. Molecular identification revealed Y4 to be Candida tropicalis AUMC 15,533 through ITS rRNA sequencing and phylogenetic analysis. Structural characterization using ¹H NMR and FT-IR confirmed the presence of β-1,3 and β-1,6 glucan linkages. Optimization of β-glucan production via Plackett–Burman design identified glucose, yeast extract, shaking speed, and incubation time as critical factors, achieving a maximum yield of 0.42 g/100 mL. The extracted β-glucan demonstrated significant biological activities, including antioxidant capacity (IC₅₀= 18.31 µg/mL), wound healing efficacy (80.19% closure in 24 h), and anti-inflammatory effects, as evidenced by reduced expression of pro-inflammatory cytokines TNF-α (74.5% reduction) and IL-6 (80.8% reduction). Carboxymethylated β-glucan showed lower but still substantial activity across all assays. These findings highlight the superior biosynthetic capacity of marine C. tropicalis for β-glucan production and its potential therapeutic properties. This study underscores the importance of exploring marine microbial diversity for potential bioactive molecules with biomedical applications.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0